Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-03-20 | Paul K. Wotton, Ph.D., a director since January 2015... Ms. Hagen (Chair), Dr. Zerbe and Dr. Wotton were members of the Governance Committee during the fiscal year ended December 31, 2019... DIRECTOR COMPENSATION FOR THE YEAR ENDED DECEMBER 31, 2019: Paul K. Wotton: $218,085. |
| 2021-03-19 | Paul K. Wotton, Ph.D., a director since January 2015, currently serves on the board of directors and is the Chief Executive Officer of Obsidian Therapeutics, Inc. ... Dr. Wotton received his Bachelor’s in Pharmacy, with honors, from University College London, his Ph.D. in pharmaceutical sciences from the University of Nottingham and his M.B.A. from Kingston Business School. ... Vericel Board committee(s): Governance and Nominating Committee ... Director compensation table: Paul K. Wotton Fees Earned or Paid in Cash($) 45,000, Stock Awards($) 25,480, Option Awards($) 117,439, Total($) 187,919. |
| 2022-03-17 | Paul K. Wotton, Ph.D., a director since January 2015. ... Vericel Board committee(s): Governance and Nominating Committee ... Director compensation table: Paul K. Wotton total $475,595. |
Data sourced from SEC filings. Last updated: 2026-02-03